| Katrina Borges, MS, OTR/L | |
|
765 Allens Ave Ste 200, Providence, RI 02905-5443 | |
| (401) 432-6800 | |
| Not Available |
| Full Name | Katrina Borges |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 765 Allens Ave Ste 200, Providence, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760072334 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Katrina Borges, MS, OTR/L 205 Sherman Ave, Seekonk, MA 02771-4913 Ph: (508) 431-6354 | Katrina Borges, MS, OTR/L 765 Allens Ave Ste 200, Providence, RI 02905-5443 Ph: (401) 432-6800 |
News Archive
With the federal law's fate uncertain, action taken so far by the states - either to implement the national overhaul or to advance reforms of their own - have claimed more significance and headlines.
When a mosquito begins to nibble on you, it is not merely feeding on your blood, it is also injecting its saliva into your skin. If that saliva happens to be full of parasites carrying malaria or other diseases from its last victim, then most likely you will become infected, too.
Receptos, Inc., a privately held biopharmaceutical company, announced the closing of a two-tranche $25 million Series A financing. The company is focused on identifying and developing best- and first-in-class GPCR therapeutic candidates through information-driven drug discovery, including GPCR structure. Investors include ARCH Venture Partners, Flagship Ventures, Lilly Ventures and Venrock.
Scientists at the University of California, San Diego and the Moores UCSD Cancer Center have evidence of a potential new biomarker to predict the aggressiveness of an often difficult-to-treat form of leukemia.
Bristol-Myers Squibb Company and Pfizer report that preliminary results from the Phase 3 AVERROES clinical trial of the investigational drug apixaban compared with acetylsalicylic acid (ASA, or aspirin) in patients with atrial fibrillation expected to be or demonstrated to be unsuitable for warfarin therapy will be presented at the European Society of Cardiology Congress 2010. The results will be presented during the "Hot Line" session on August 31, 2010, in Stockholm, Sweden.
› Verified 1 days ago
Caitlin Kelly, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Eddy St, Providence, RI 02905 Phone: 401-533-9100 | |
Allison Marie Hourahan, OTR/L, CLT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 668 Eddy St, Providence, RI 02903 Phone: 401-274-1122 | |
Ms. Diana Navarro, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 353 Blackstone Blvd, Providence, RI 02906 Phone: 401-273-6565 | |
Mrs. Kelly L. Klampert, OTR L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Eddy St, Providence, RI 02905 Phone: 401-533-9100 | |
Kristen Laurie Bourque, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Eddy St, Providence, RI 02905 Phone: 401-533-9165 Fax: 401-533-9105 | |
Miss Christa N Fadden, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-444-8661 | |
Miss Melissa Anne Barlow, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 164 Summit Ave, Providence, RI 02906 Phone: 401-793-5080 |